Publications
2020
Biomark. Res. 8:46 (2020)
Mol. Ther.-Oncolytics 18, 504-524 (2020)
Proc. Natl. Acad. Sci. U.S.A. 117, 12961-12968 (2020)
Clin. Transl. Immunology 9:e1117 (2020)
Semin. Immunopathol., accepted (2020)
Nat. Commun. 11:685 (2020)
2019
J. Mol. Biol. 431, 4910-4921 (2019)
Cell 179, 1661-1676 (2019)
Eur. J. Immunol. 49, 130-130 (2019)
Eur. J. Immunol. 49, 99-100 (2019)
Eur. J. Immunol. 49, 112-112 (2019)
Eur. J. Immunol. 49, 25-26 (2019)
Bone Marrow Transplant. 54, 177-178 (2019)
mBio 10:e01723-19 (2019)
Proc. Natl. Acad. Sci. U.S.A. 116, 16046-16055 (2019)
Life Sci. All. 2:e201800108 (2019)
Acta Neurochir. 161, 1109-1124 (2019)
Nat. Commun. 10:1415 (2019)
J. Extra. Vesicles 8:1573051 (2019)
Cell. Mol. Immunol. 16, 412-414 (2019)
mBio 10:01941-18 (2019)
Eur. J. Immunol. 49, 351-352 (2019)
2018
Poster: International Conference on EBV & KSHV 2018, 28 July - 01 August 2018, Madison. (2018)
J. Immunol. 202, 979-990 (2018)
Nat. Commun. 9:3839 (2018)
PLoS Biol. 16:e2005233 (2018)
Immunity, accepted (2018)
Oncotarget 9, 26800-26816 (2018)
J. Transl. Med. 16:124 (2018)
PLoS ONE 13:e0193554 (2018)
Cancer Med. 7, 2013-2020 (2018)
Nucl. Med. Biol. 60, 55-62 (2018)
Cell Rep. 22, 992-1002 (2018)
Cancer Immunol. Immunother. 67, 663-674 (2018)
2017
PLoS Pathog. 13, e1006664:e1006664 (2017)
Vaccine 35, 5131-5139 (2017)
J. Virol. 91:e01667-16 (2017)
Haematologica 102, 883-894 (2017)
Nat. Commun. 8:14715 (2017)
Haematologica 102, e69-e72 (2017)
2016
Blood 128, 2517-2526 (2016)
Proc. Natl. Acad. Sci. U.S.A. 113, E6467-E6475 (2016)
J. Exp. Med. 213, 2065-2080 (2016)
Haematologica 101, 1, 574-574 (2016)
Nat. Commun. 7:12597 (2016)
J. Clin. Immunol. 36, 684-692 (2016)
Cancer Immunol. Res. 4:B146 (2016)
J. Biomol. Screen. 21, 596-607 (2016)
Nucleic Acids Res. 44, 4636-4650 (2016)
PLoS Pathog. 12:e1005383 (2016)
Leukemia 30, 1166-1176 (2016)
2015
Oncol. Res. Treat. 38, 37 (2015)
Front. Immunol. 6:598 (2015)
Curr. Opin. Virol. 14, 138-144 (2015)
Curr. Top. Microbiol. Immunol. 390, 103-117 (2015)
Curr. Top. Microbiol. Immunol. 391, 119-149 (2015)
Curr. Top. Microbiol. Immunol. 391, 35-39 (2015)
PLoS Pathog. 11:e1004906 (2015)
PLoS Pathog. 11:e1004910 (2015)
Nat. Commun. 6:7030 (2015)
Bone Marrow Transplant. 50, S400 (2015)
J. Enzyme Inhib. Med. Chem. 30, 955-960 (2015)
Sci. Transl. Med. 7:282ra47 (2015)
J. Chem. Inf. Model. 55, 294-307 (2015)
J. Immunol. 194, 1434-1445 (2015)
J. Exp. Med. 212, 37-52 (2015)
Bioinformatics 31, 933-939 (2015)
2014
Oncol. Res. Treat. 37, 70 (2014)
Nucleic Acids Res. 42, 9700-9716 (2014)
Cancer Res. 74, 4318-4328 (2014)
J. Immunol. 192, 5894-5905 (2014)
Eur. J. Cancer 50, 1291-1300 (2014)
Biomaterials 35, 4345-4356 (2014)
Nucleic Acids Res. 42, 3666-3674 (2014)
Nucleic Acids Res. 42, 3059-3072 (2014)
Oncogene 44, 1258-1264 (2014)
2013
PLoS ONE 8:e80312 (2013)
PLoS ONE 8:e80908 (2013)
PLoS ONE 8:e56420 (2013)
Front. Immunol. 4:33 (2013)
Cancer Res. 73, 6494-6503 (2013)
Curr. Opin. Virol. 3, 260-265 (2013)
Hepatology 57, 2469-2479 (2013)
PLoS Pathog. 9:e1003383 (2013)
PLoS Pathog. 9:e1003336 (2013)
Sci. Signal. 6:ra27 (2013)
Mol. Cell 49, 668-679 (2013)
Cold Spring Harbor Perspect. Biol. 5:a013029 (2013)
J. Gen. Virol. 94, 376-386 (2013)
2012
Eur. J. Immunol. 42, 2901-2912 (2012)
PLoS Pathog. 8:e1002704 (2012)
Cell Death Dis. 3:e414 (2012)
Eur. J. Immunol. 42, 3167-3173 (2012)
J. Immunol. 189, 3795-3799 (2012)
PLoS Pathog. 8:e1002902 (2012)
PLoS ONE 7:e42021 (2012)
Proc. Natl. Acad. Sci. U.S.A. 109, E1396-E1404 (2012)
J. Virol. 86, 447-458 (2012)
Eur. J. Cell Biol. 91, 97-101 (2012)
Eur. J. Cell Biol. 91, 65-69 (2012)
2011
Biodistribution of 131I-labeled anti-CK8 monoclonal antibody in HNSCC in xenotransplanted SCID mice.
Anticancer Res. 31, 3315-3321 (2011)
Laryngol. Rhinol. Otol. 90, 168-177 (2011)
J. Virol. 85, 13105-13113 (2011)
Pharm. Unserer Zeit 40, 240-246 (2011)
Cell. Mol. Life Sci. 68, 3741-3756 (2011)
Blood 118, 6321-6331 (2011)
Blood 117, 1777-1778 (2011)
Blood 117, 3780-3792 (2011)
Cancer Immunol. Immunother. 60, 649-658 (2011)
Cancer Immunol. Immunother. 60, 639-648 (2011)
2010
HNO 58, 713-723 (2010)
Vortrag: 14th International Congress of Immunology, 22- 27 August 2010, Kobe, Japan. (2010)
In: Robertson, E.S.* [Eds.]: Epstein-Barr Virus. Latency and Transformation. Norfolk: Caister Academic Press, 2010. 61-80
Blood 115, 2960-2970 (2010)
PLoS Pathog. 6, 69-70:e1001063 (2010)
J. Virol. 84, 3612-3623 (2010)
J. Neurosci. 30, 13794-13807 (2010)
Cell. Mol. Life Sci. 67, 4249-4256 (2010)
Proc. Natl. Acad. Sci. U.S.A. 107, 13438-13443 (2010)
J. Exp. Med. 207, 1031-1044 (2010)
PLoS Pathog. 6, e1001114 (2010)
Proc. Natl. Acad. Sci. U.S.A. 107, 850-855 (2010)
J. Immunol. 184, 1617-1629 (2010)
Virology 397, 299-310 (2010)
2009
J. Immunol. 183, 6819-6830 (2009)
PLoS Pathog. 5:e1000506 (2009)
Cell Commun. Signal. 7:2 (2009)
Sci. Signal. 2, mr3:mr3 (2009)
Vortrag: KSHV 12th International Workshop, 13-16 September 2009, Charleston, South Carolina, USA. (2009)
Vortrag: Eukaryotic DNA Replication and Genome Maintenance, 1-5 September 2009, Cold Spring Harbor, NY, USA. (2009)
2008
Biol. Chem. 389, 1261-1271 (2008)
Development 135, 2757-2765 (2008)
Hepatology 48, 607-616 (2008)
PLoS ONE 3:e1464 (2008)
Nucleic Acids Res. 36:e83 (2008)
J. Exp. Med. 205, 1317-1329 (2008)
Mol. Immunol. 45, 3230-3237 (2008)
Proc. Natl. Acad. Sci. U.S.A. 105, 1692-1697 (2008)
PLoS Biol. 6, 86-98:e8 (2008)
2007
Signal Transduct. 7, 20-33 (2007)
Anticancer Res. 27, 431-436 (2007)
Cancer Genomics Proteomics 4, 349-358 (2007)
Cancer Immunol. Immunother. 56, 1645-1652 (2007)
Apoptosis 12, 1927-1943 (2007)
Cancer Immunol. Immunother. 56, 1645-1652 (2007)
Cancer Immunol. Immunother. 56, 1429-1442 (2007)
In: Krebsimmuntherapien. Köln: Deutscher Ärzte-Verl., 2007. 175-182
J. Virol. 81, 10092-10100 (2007)
Hum. Immunol. 68, 75-85 (2007)
Biol. Chem. 388, 1083-1090 (2007)
Blood 110, 3715-3721 (2007)
J. Virol. 81, 2274-2282 (2007)
Anticancer Res. 26, 783-789 (2007)
J. Exp. Med. 204, 331-343 (2007)
Dev. Dyn. 236, 282-289 (2007)
2006
Anticancer Res. 26, 153-158 (2006)
Blood 108, 3859-3864 (2006)
Proc. Natl. Acad. Sci. U.S.A. 103, 14188-14193 (2006)
J. Gen. Virol. 87, 3169-3176 (2006)
Int. J. Immunopathol. Pharmacol. 19, 49-59 (2006)
Mol. Carcinog. 45, 957-967 (2006)
Gene Ther. 13, 844-856 (2006)
J. Exp. Med. 203, 995-1006 (2006)
J. Virol. 80, 9761-9771 (2006)
Blood 107, 4433-4439 (2006)
Gene Ther. 13, 150-162 (2006)
2005
Epstein-Barr Virus provides a new paradigm: A requirement for the immediate inhibition of apoptosis.
PLoS Biol. 3, 2148-2157:e404 (2005)
Blood 106, 4339-4344 (2005)
In: Robertson, E.S.* [Eds.]: Epstein-Barr Virus. Norwich: Caister Acad. Press, 2005. 463-499
Anticancer Res. 25, 4239-4243 (2005)
Oncogene 24, 1711-1717 (2005)
Cancer Lett. 225, 151-157 (2005)
Eur. J. Immunol. 35, 2250-2258 (2005)
Eur. J. Immunol. 35, 2110-2121 (2005)
Blood 105, 3263-3269 (2005)
2004
J. Virol. 78, 12694-12697 (2004)
Trends Mol. Med. 10, 331-336 (2004)
J. Exp. Med. 199, 1409-1420 (2004)
Gene 343, 91-97 (2004)
Cell. Mol. Life Sci. 61, 1198-1207 (2004)
Eur. J. Immunol. 34, 2500-2509 (2004)
Cancer Genomics Proteomics 1, 241-248 (2004)
Cancer Genomics Proteomics 1, 167-176 (2004)
Anticancer Res. 24, 887-894 (2004)
Oncogene 23, 5748-5758 (2004)
Biochem. Biophys. Res. Commun. 323, 156-162 (2004)
2003
Anticancer Res. 23, 3255-3262 (2003)
Int. J. Immunopathol. Pharmacol. 16, 41-48 (2003)
FASEB J. 17, 286-288 (2003)
J. Cell Sci. 116, 3971-3984 (2003)
Cancer Res. 63, 2982-2989 (2003)
Proc. Natl. Acad. Sci. U.S.A. 100, 10989-10994 (2003)
J. Virol. 77, 8290-8298 (2003)
2002
HNO 50, 1075-1078 (2002)
Proc. Natl. Acad. Sci. U.S.A. 99, 437-442 (2002)
Cancer Res. 62, 2267-2271 (2002)
Proc. Natl. Acad. Sci. U.S.A., 1-6 (2002)
J. Virol. 76, 9635-9644 (2002)
2001
Philos. Trans. R. Soc. B - Biol. Sci. 356, 437-459 (2001)
Methods Mol. Biol. 174, 313-323 (2001)
Eur. J. Cancer 1, S61 (2001)
Anticancer Res. 21, 3499-3503 (2001)
Laryngol. Rhinol. Otol. 80, 191-195 (2001)
2000
J. Virol. 74, 1727-1735 (2000)
J. Virol. 74, 10142-10152 (2000)
FEBS J. 267, 3891-3901 (2000)
FASEB J. 14, 661-668 (2000)
1999
EMBO J. 18, 3064-3673 (1999)
Anticancer Res. 19, 2237-2242 (1999)
Arch. Otolaryngol. Head Neck Surg. 125, 82-88 (1999)
Anticancer Res. 19, 5335-5339 (1999)
Laryngol. Rhinol. Otol. 78, 36-40 (1999)
Proc. Natl. Acad. Sci. U.S.A. 96, 5188-5193 (1999)
1998
Proc. Natl. Acad. Sci. U.S.A. 95, 8245-8250 (1998)
Int. J. Mol. Med. 2, 167-171 (1998)
1997
Clin. Cancer Res. 3, 573-578 (1997)
Blood 90, 2390-2397 (1997)
EMBO J. 16, 6131-6140 (1997)
Eur. Arch. Otorhinolaryngol. 254, S130-S132 (1997)
Laryngol. Rhinol. Otol. 76, 411-414 (1997)
1996
Int. J. Cancer 68, 577-582 (1996)
Cancer Res. 56, 5610-5614 (1996)
J. Gen. Virol. 77, 2807-2818 (1996)
1995
Virology 206, 93-99 (1995)
J. Virol. 69, 231-238 (1995)
Eur. J. Immunol. 25, 792-797 (1995)
Proc. Natl. Acad. Sci. U.S.A. 92, 5875-5879 (1995)
1994
Genes Chromosomes Cancer 9, 282-287 (1994)
1993
J. Virol. 67, 1292-1299 (1993)
Exp. Hematol. 21, 74-79 (1993)
In: Turesz, T.* [Eds.]: Proceedings (Proc. of the 5th Intern. Symp. on EBV and Associated Disesases, Annecy, Frankreich, 13.-19. Sept. 1992). Montrouge, Frankreich: John Libbey Eurotext, 1993. 159-164 ( ; 225)
J. Virol. 67, 4237-4245 (1993)
J. Biol. Chem. 268, 12544-12551 (1993)
In: Tursz, T.* [Eds.]: The Epstein-Barr Virus and Associated Diseases. Montrouge, Frankreich: John Libbey Eorotext, 1993. 245-252 ( ; 225)
In: Tursz, T.* [Eds.]: Proceedings (The Epstein-Barr Virus and Associated Diseases, Annecy, Frankreich, 13.-19. Sept. 1992). Montrouge, Frankreich: John Libbey Eurotext, 1993. 211-217 ( ; 225)
In: Tursz, T.* [Eds.]: The Epstein-Barr Virus and Associated Diseases. Montrouge, Frankreich: John Libbey Eurotext, 1993. 83-88 ( ; 225)
Exp. Hematol. 21, 74-79 (1993)
J. Virol. 67, 1292-1299 (1993)
J. Virol. 67, 4237-4245 (1993)
J. Virol. 67, 82-92 (1993)
1991
Semin. Virol. 2 (1991)
J. Virol. 65, 415-423 (1991)
1990
Curr. Top. Microbiol. Immunol. 166, 359-366 (1990)
Curr. Top. Microbiol. Immunol. 166, 359-366 (1990)